Steve Tutewohl, Chief Operating Officer at Evolent Health, Inc. (EVH), sold 1,707 shares at $22.85 ($39K) on 2022-02-03, disclosed to the SEC on 2022-02-07.
Scheduled sale ($39k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| EVH | SELL | 2022-02-01 | $296K | — | Filing → |
| EVH | SELL | 2021-09-02 | $679K | — | Filing → |
| EVH | SELL | 2021-08-04 | $1.4M | — | Filing → |